Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6045698 | World Neurosurgery | 2014 | 7 Pages |
Abstract
The survival rate was better in patients with spinal metastases who received specific treatment. The evolution from lytic spinal metastasis to mixed and blastic subtypes is observed with adjunctive therapy for spinal metastases (bisphosphonates, radiotherapy). Increased attention must be given for high-grade breast cancer, as spinal metastases declare faster for these stages. This study provides evidence that a multidisciplinary tumor board specifically focusing on bone metastasis is essential to effectively manage patients with breast cancer and spinal metastasis.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Emilie Chan-Seng, Marie Charissoux, Ahmed Larbi, Raphäel Tétreau, Yannick Nicolas Gerber, Delphine De Verbizier-Lonjon, François Segnarbieux, Nicolas Lonjon,